Have you heard about the Israeli cancer cure? A small tech firm in Israel says they will have a complete cure for cancer within a year. They say it will have “no or minimal side-effects at a much lower cost than most other treatments on the market.” It will also supposedly work against almost every kind and stage of cancer.
That would be quite a change from toxic and expensive cancer therapies, that can cost as much as $475,000 per infusion. Plus, curing cancer would be far superior to involving patients in long-drawn-out “chronic treatments” that fall short of getting rid of the disease.
The story of the Israeli cancer cure first ran in the Jerusalem Post and quickly made headlines around the world, including at The New York Post, NBC, and the US News. That once reputable source repeated this claim:
“The team says its treatment will be effective from Day One.”
This new cancer remedy is called MuTaTo. The name stands for multi-target toxins. The treatment is designed to attack three cancer cell receptors at the same time. This supposedly makes it work faster than cancer cells can possibly mutate.
“And, because the cells would be killed,” U.S. News assured its readers, “patients could likely stop treatment after a number of weeks and not need a drug cocktail throughout their lives….”
An Effective Cancer Remedy?
In other words, what has been dubbed “the Israeli cancer cure,” checks all the boxes. It is simple, cheap, non-toxic, and fast acting. And it works on all types of cancer without exception. In other words, it is a complete cancer remedy.
This is the dream of all mankind. But if you read these articles carefully, as you should, you begin to notice a few strange things.
First of all, top company executives, Dan Aridor and Ilan Morad, PhD, are basing their claims on studies in test tubes and lab rats. No patients have yet been tested.
Who are these folks making bold claims?
However, a quick search of the company website and the PubMed database turns up no relevant articles by these individuals, or their company Accelerated Evolution Biotechnologies Ltd., or AEBi. At Dan Aridor’s website it lists his accomplishments as aiding in the purchase of a quarter of a billion dollar hedge fund. That’s impressive from a financial point of view, but hardly qualifies him to speak on scientific topics.
Ilon Morad, PhD, is a Tel Aviv scientist and company CEO. He has half a dozen PubMed-listed papers on various topics, dating from the 1990s.But I don’t see any that he hasn’t published on this particular topic.
Mr. Morad is quoted as saying the company has not published their research in medical journals because it “can’t afford” to do so. That’s falling-down hysterical. Most journals do not charge a fee for publication. And even if they do, the cost is usually about a thousand dollars or so.
Since a universal cancer cure would make, not millions, but tens of billions of dollars, publishing scientific reports to prepare the world for this development is the least they can do. In fact, anyone who doesn’t do so is highly suspect.
Is This the Cure for Cancer?
Another thing that jumps out about the “Israeli cancer cure” is the lack of clinical research. They claim to have a cure for cancer. But at this point we do not know how their treatment would perform in human patients, and not just in lab mice.
Results in experimental animals may suggest promising avenues for further research. But they are no guarantee of benefit. For instance, when the Nobel laureate James D. Watson, PhD, was overheard saying that Harvard Prof. Judah Folkman, MD, would cure cancer “within two years,” Folkman humorously replied:
His point was that creating a cancer remedy for human patients is much more difficult than curing it in lab mice. And this is what history has shown. That story broke on the front page of the New York Times in 1998. Sadly, Judah Folkman died in 2008. Now, a decade later, his promising treatment is still not available for humans. This despite the fact that Folkman did everything right, publishing over 270 papers on cancer alone in leading journals.
So is “MuTaTo” the real deal? Some Israeli scientists tell me that they are intrigued by the company’s concepts. So maybe these bold claims of a ‘cure’ will come true. Let us hope so. I have reached out to the company and they promised me some further information. But so far I haven’t heard back.
This Israeli cancer cure could of course backfire. Israel has a reputation for medical advances. But most Israeli scientists have rejected these MuTaTo claims, calling them spurious, irresponsible, unsubstantiated and even cruel. I don’t think this is the way to announce a breakthrough. But too much is at stake to reject the claims out of hand. We need to keep watching this development to see if anything comes of it.